A Memorial Sloan Kettering Cancer Center study reveals new details about how pancreatic cells carrying oncogenic mutations ...

Description: The Comba Laboratory, located within the Department of Pathology, Division of Neuropathology, focuses on understanding how tumor-derived extracellular matrix (ECM) remodeling reshapes the ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, ...

Spatial biology is a rapidly advancing discipline that examines biological molecules (such as DNA, RNA, and proteins) within their native locations in tissues. This approach offers critical insight ...

The South Korean spatial biology company unveils new AI agents, foundation models, and spatial biomarkers for oncology drug discovery. SEOUL, South Korea, /PRNewswire/ -- Portrai, Inc. today announced ...

10x Genomics TXG recently unveiled Atera, a next-generation in situ spatial biology platform designed to deliver ...

While factors for disease, such as genetic risk, have been extensively identified, their presence alone does not determine progression to disease. To understand what’s driving oncogenesis across ...

10x Genomics is undervalued, with a BUY rating and 18% upside to a $20.47 target, driven by robust consumables growth. Consumables, comprising 83% of revenue, continue double-digit growth, offsetting ...

As the “Method of the Year 2024”, spatial proteomics (SP) enables in situ characterization of protein localization, abundance ...